Association between Lactococcus cremoris subsp. cremoris FC intake and microbiota profiles in relation to bowel movement: a post hoc analysis of a placebo-controlled, parallel-group trial
Bioscience of Microbiota, Food and Health · 2026 · 45 (3) · 217-224
DOI: 10.12938/bmfh.2026-001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioscience of Microbiota, Food and Health, 2026. Verfasst von Yoshiyuki Tabata und 3 weiteren Autor:innen. Beteiligte Einrichtung: Fujicco Co., Ltd., Innovation Center, 6-13-4 Minatojima-Nakamachi, Chuo-ku, Kobe-shi, Hyogo 650-8558, Japan. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Fujicco Co., Ltd., Innovation Center, 6-13-4 Minatojima-Nakamachi, Chuo-ku, Kobe-shi, Hyogo 650-8558, Japan.
Zitieren
APA
Tabata, Y., Gotoh, Y., Watanabe, M., & Maruyama, K. (2026). Association between Lactococcus cremoris subsp. cremoris FC intake and microbiota profiles in relation to bowel movement: a post hoc analysis of a placebo-controlled, parallel-group trial. Bioscience of Microbiota, Food and Health, 45(3), 217-224. https://doi.org/10.12938/bmfh.2026-001
Vancouver
Tabata Y, Gotoh Y, Watanabe M, Maruyama K. Association between Lactococcus cremoris subsp. cremoris FC intake and microbiota profiles in relation to bowel movement: a post hoc analysis of a placebo-controlled, parallel-group trial. Bioscience of Microbiota, Food and Health. 2026;45(3):217-224. doi:10.12938/bmfh.2026-001
BibTeX
@article{Tabata2026,
author = {Tabata, Yoshiyuki and Gotoh, Yayoi and Watanabe, Masamichi and Maruyama, Kentaro},
title = {Association between Lactococcus cremoris subsp. cremoris FC intake and microbiota profiles in relation to bowel movement: a post hoc analysis of a placebo-controlled, parallel-group trial},
journal = {Bioscience of Microbiota, Food and Health},
year = {2026},
volume = {45},
number = {3},
pages = {217--224},
doi = {10.12938/bmfh.2026-001}
}
EUVIMED